New hope for rare blood cancer: targeted pill tested in japanese patients
NCT ID NCT07387471
First seen Feb 04, 2026 · Last updated May 21, 2026 · Updated 19 times
Summary
This study tests a drug called venetoclax in about 14 Japanese adults with a rare blood cancer (Waldenström macroglobulinemia) that has returned or stopped responding to prior therapy. Participants take venetoclax pills daily, with doses slowly increased to a target level. The main goal is to see how many people have a major reduction in cancer activity, while also monitoring side effects and overall survival over about 28 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOPLASMACYTIC LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chiba Cancer Center /ID# 279177
RECRUITINGChiba, 260-0801, Japan
-
Gunma University Hospital /ID# 277576
RECRUITINGMaebashi, Gunma, 371-8511, Japan
-
Hiroshima University Hospital /ID# 279172
RECRUITINGHiroshima, 734-8551, Japan
-
Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital /ID# 279178
RECRUITINGNagoya, Aichi-ken, 466-8650, Japan
-
Japanese Red Cross Medical Center /ID# 277577
RECRUITINGShibuya-ku, Tokyo, 150-8935, Japan
-
Kindai University Hospital /ID# 277587
RECRUITINGSakai-shi, Osaka, 590-0197, Japan
-
Kyushu University Hospital /ID# 277582
RECRUITINGFukuoka, Fukuoka, 812-8582, Japan
-
NHO Mito Medical Center /ID# 279175
RECRUITINGHigashiibaraki-gun, Ibaraki, 311-3193, Japan
-
Nagoya City University Hospital /ID# 277580
RECRUITINGNagoya, Aichi-ken, 467-8602, Japan
-
National Cancer Center Hospital /ID# 279076
RECRUITINGChuo-Ku, Tokyo, 104-0045, Japan
-
National Hospital Organization Disaster Medical Center /ID# 277741
RECRUITINGTachikawa, Tokyo, 190-0014, Japan
-
The Cancer Institute Hospital Of JFCR /ID# 277579
RECRUITINGKoto-ku, Tokyo, 135-8550, Japan
-
The University of Tokyo Hospital /ID# 279174
RECRUITINGBunkyo-ku, Tokyo, 113-8654, Japan
-
University Hospital Kyoto Prefectural University of Medicine /ID# 277584
RECRUITINGKyoto, Kyoto, 602-8566, Japan
-
University of Fukui Hospital /ID# 279173
RECRUITINGYoshida-gun, Fukui, 910-1104, Japan
-
University of Yamanashi Hospital /ID# 279179
RECRUITINGChuo-shi, Yamanashi, 409-3898, Japan
Conditions
Explore the condition pages connected to this study.